Lv1
38 积分 2022-11-01 加入
Tolerogenic immunoreceptor ILT3/LILRB4 paradoxically marks pathogenic auto-antibody-producing plasmablasts and plasma cells in non-treated SLE
22天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2个月前
已完结
Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
2个月前
已完结
IgA nephropathy
2个月前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
2个月前
已完结
[Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)]
2个月前
已完结
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
4个月前
已完结
Elevated Myostatin Levels in Patients with Liver Disease
4个月前
已完结
Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
5个月前
已完结
Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
5个月前
已完结
皖公网安备34019202002308
